30 Apr, EOD - Indian

SENSEX 80242.24 (-0.06)

Nifty 50 24334.2 (-0.01)

Nifty Bank 55087.15 (-0.55)

Nifty IT 35794.95 (-0.35)

Nifty Midcap 100 54124.9 (-0.85)

Nifty Next 50 64508.85 (-0.59)

Nifty Pharma 21772.45 (0.44)

Nifty Smallcap 100 16448.85 (-1.73)

30 Apr, EOD - Global

NIKKEI 225 36452.3 (1.13)

HANG SENG 22119.41 (0.51)

S&P 5656.18 (1.18)

LOGIN HERE

companylogoDr Lalchandani Labs Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 541299 | NSE Symbol : | ISIN : INE871Z01013 | Industry : Healthcare |


Chairman's Speech

Dr Arjan Lalchandani Chairman & Managing Director

Dear Shareholders,

It is my pleasure to welcome you all to the 06th Annual General Meeting of Dr Lalchandani Labs Limited for the year 2022-2023.

Dr Lalchandani Labs Limited is a NABL accredited lab functional in the area of pathology, radiology, hospital lab management, doctor consultation, corporate health check-ups since the inception of our pathology lab as a proprietorship firm in the year 1986 and we have been trying to cater our clients with excellent pathology and diagnostic services. In order to achieve the said goal, we arrange various training programs for our staff members to equip them with the latest technologies and amendments to cope up with the changing needs of the market.

We expect Dr Lalchandani Labs Limited to be one of the top listed laboratories offering pathology and diagnostic services in the next 5 years with various labs and diagnostic centers at different regions of the country.

The company has a strong belief to fulfill its commitment and make all dedicated as well as sincere efforts in executing its planning and strategies. Accordingly, the company spreading its wings in almost each and every corner of India by developing the requisite infrastructure in order to provide desired/ satisfactory services to our valued customers.

The growth of the company could not be well accelerated without the help of our lending institutes who have supported our liquidity requirements at the continuous interval, we are generous to have their confidence in our vision and future prospects.

In the end, I would also like to place on record my sincere thanks to all our well-wishers, associates, vendors, customers, employees and members of the Board who have contributed to the success of your Company. Lastly, I would also like to thank all the stakeholders for their loyalty and continuous support in helping us achieve our vision of bringing quality health care to our society and also look forward to a positive interaction with all in the days to come.

Sd/-
Dr. Arjan Lalchandani
Chairman & Managing Director
Dr Lalchandani Labs Limited

   

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +